Want a lightning-fast tour of the latest issue? Take a look at our new video sneak preview.
“Extraordinary” results from a T-cell therapy trial offer hope to leukemia patients – and to researchers toiling in unfashionable fields.
A gene therapy approach for hemophilia-causing Factor VII deficiency shows early promise
John Ahrens and Joseph C. Wu
A decade after Shinya Yamanaka brought us induced pluripotent stem cells, our ability to generate an endless supply of human heart cells is being put to good use in research and development.
It’s often difficult to target pancreatic cancer cells while sparing healthy tissue – but a new therapy concept not only makes this possible, but also enhances the potential effectiveness of adjuvant treatments
When genetics yielded unsatisfactory answers about pancreatic cancer’s persistent survival, researchers looked beyond the genome – and found telling epigenetic changes
A new immunotherapy approach shows that engineered T cells are able to penetrate into pancreatic tumors and directly attack the cancer
The epithelial-to-mesenchymal transition in pancreatic cancer may play a role in its resistance to treatment – and inhibiting it may improve treatment efficacy
Pancreatic cancer is tough to understand, diagnose and treat. Undeterred researchers are on a quest to crack the case.
Researchers at MIT have programmed induced pluripotent stem cells to form rudimentary livers, complete with different tissues, by engineering expression of GATA6.
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.